Phio Pharmaceuticals Corp.

0.92 USD
-0.01 (-1.16%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Phio Pharmaceuticals Corp. stock is down -14.67% since 30 days ago. The next earnings date is Mar 20, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 16.67% of the previous 11 December’s closed higher than November.

About Phio Pharmaceuticals Corp.

Phio Pharmaceuticals Corp. develops immuno-oncology therapeutics in the United States. Company develops PH-762 that activates immune cells to recognize and kill cancer cells by reducing the expression of the checkpoint protein PD-1 for immunotherapy in adoptive cell transfer (ACT) PH-894 that silences the epigenetic protein BRD4, which is an intracellular regulator of gene expression.